UAB’s Jack Hasson has been named the 2017 Outstanding Clinician by the American Thoracic Society.
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
The winners of the first SPARC competition, an initiative between UAB Medicine and Medscape, will share $40,000 in grants for quality improvement projects.
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.
Moon Nahm’s research has led to improvements in testing effectiveness of pneumonia vaccines, a key step to preventing deaths from S. pneumoniae, the leading cause of pneumonia estimated to kill 1.6 million children annually.
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Exacerbations of COPD, particularly mild COPD, lead to a decline in lung function in smokers, according to new research from UAB.